首页> 外文OA文献 >Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. Cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.

【2h】

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. Cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.

机译：单独含有4mg卓越酮酮的新雌激素无避孕药的疗效和心血管安全性在24/4方案中。在24/4制度中单独含有4mg替代龙酮的新雌激素免避孕药的心血管安全。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Santiago Palacios; Enrico Colli; Pedro Antonio Regidor;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4?mg drospirenone alone in a 24/4 regime [J] . Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor BMC Women s Health . 2020,第1期

机译：单独含有4μmMg卓越龙酮的新雌激素无避孕药的疗效和心血管安全性在24/4制度中
2. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: Final results from the International Active Surveillance Study of Women Taking Oral Contraceptives [J] . DingerJ., BardenheuerK., HeinemannK. Contraception . 2014,第4期

机译：含屈螺酮的联合口服避孕药24天疗程的心血管和总体安全性：口服避孕药的妇女国际主动监视研究的最终结果
3. Multicenter, phase III III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill [J] . Palacios Santiago, Colli Enrico, Regidor Pedro‐Antonio Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi . 2019,第12期

机译：多中心，第III期III试验对避孕药的避孕效果，可耐受性和安全性的唯一唯一的卓越龙酮药丸
4. Efficacy and Safety of Didanosine (ddI) and Tenofovir (TDF) Combination as NRTI Backbone of Highly Active Antiretrovirai Treatment (HAART). (24 wk Preliminary Results from Recover Study). [C] . M.J. Galindo, J. Lopez Aldeguer, M. Salavert International AIDS Conference . 2004

机译：脱蛋白（DDI）和替诺福韦（TDF）组合作为高活性抗逆转录（HAART）的NRTI骨架的疗效和安全性。（恢复研究中的24条WK初步结果）。
5. Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime [O] . Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor 2020

机译：单独含有4毫克卓越龙酮的新雌激素无避孕药的疗效和心血管安全性在24/4制度中
6. Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime [O] . Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor 2020

机译：单独含有4毫克卓越龙酮的新雌激素无避孕药的疗效和心血管安全性在24/4制度中

Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. Cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime.

著录项

引文网络

相似文献

相关主题

期刊订阅